G
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A102.9 KBGlobal Blood Therapeutics, Inc.Feb 14, 8:34 AM ET·0001172661-23-000829
- SC 13G/A8.1 KBGlobal Blood Therapeutics, Inc.Feb 9, 10:59 AM ET·0000315066-23-001628
- 8-K361.3 KBGlobal Blood Therapeutics, Inc.Oct 5, 4:06 PM ET·0000950157-22-001085
- 8-K183.2 KBGlobal Blood Therapeutics, Inc.Sep 30, 4:06 PM ET·0000950157-22-001076
- 8-K248.0 KBGlobal Blood Therapeutics, Inc.Sep 23, 4:17 PM ET·0000950157-22-001050
- 10-Q12.1 MBGlobal Blood Therapeutics, Inc.Aug 8, 7:01 AM ET·0000950170-22-015231
- 8-K976.6 KBGlobal Blood Therapeutics, Inc.Aug 8, 6:56 AM ET·0000950157-22-000902
- 8-K240.6 KBGlobal Blood Therapeutics, Inc.Jul 26, 6:00 AM ET·0001171843-22-004988
- 8-K234.0 KBGlobal Blood Therapeutics, Inc.Jul 14, 10:05 AM ET·0001171843-22-004853
- 8-K231.6 KBGlobal Blood Therapeutics, Inc.Jun 29, 8:02 AM ET·0001171843-22-004591
Insiders
10Tickers
No tickers on record
Addresses
business
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080
mailing
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080